Journal of Hematology & Oncology (May 2017)

Wnt/beta-catenin pathway: modulating anticancer immune response

  • Sachin Gopalkrishna Pai,
  • Benedito A. Carneiro,
  • Jose Mauricio Mota,
  • Ricardo Costa,
  • Caio Abner Leite,
  • Romualdo Barroso-Sousa,
  • Jason Benjamin Kaplan,
  • Young Kwang Chae,
  • Francis Joseph Giles

DOI
https://doi.org/10.1186/s13045-017-0471-6
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Wnt/β-catenin signaling, a highly conserved pathway through evolution, regulates key cellular functions including proliferation, differentiation, migration, genetic stability, apoptosis, and stem cell renewal. The Wnt pathway mediates biological processes by a canonical or noncanonical pathway, depending on the involvement of β-catenin in signal transduction. β-catenin is a core component of the cadherin protein complex, whose stabilization is essential for the activation of Wnt/β-catenin signaling. As multiple aberrations in this pathway occur in numerous cancers, WNT-directed therapy represents an area of significant developmental therapeutics focus. The recently described role of Wnt/β-catenin pathway in regulating immune cell infiltration of the tumor microenvironment renewed the interest, given its potential impact on responses to immunotherapy treatments. This article summarizes the role of Wnt/β-catenin pathway in cancer and ongoing therapeutic strategies involving this pathway.

Keywords